Twenty-Four-Hour Simultaneous Subcutaneous Basal-Bolus Administration of Insulin and Amylin in Adolescents with Type 1 Diabetes Decreases Postprandial Hyperglycemia

Por Heptulla, Rubina A., Rodriguez, Luisa M., Mason, Kimberly J., Haymond, Morey W.
Publicado em 2009

The Role of Adjunctive Exenatide Therapy in Pediatric Type 1 Diabetes

Por Raman, Vandana S., Mason, Kimberly J., Rodriguez, Luisa M., Hassan, Krishnavathana, Yu, Xiaoying, Bomgaars, Lisa, Heptulla, Rubina A.
Publicado em 2010